BELLINI, Giulia
 Distribuzione geografica
Continente #
NA - Nord America 1.181
EU - Europa 986
AS - Asia 295
SA - Sud America 3
OC - Oceania 2
Totale 2.467
Nazione #
US - Stati Uniti d'America 1.179
IE - Irlanda 303
CN - Cina 163
UA - Ucraina 150
GB - Regno Unito 135
DE - Germania 122
IT - Italia 116
SG - Singapore 74
SE - Svezia 53
TR - Turchia 46
FI - Finlandia 39
FR - Francia 25
GR - Grecia 19
BE - Belgio 12
KR - Corea 9
NL - Olanda 4
CZ - Repubblica Ceca 3
SI - Slovenia 3
CA - Canada 2
CL - Cile 2
IN - India 2
AR - Argentina 1
AU - Australia 1
JP - Giappone 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
RU - Federazione Russa 1
Totale 2.467
Città #
Dublin 302
Chandler 265
Jacksonville 222
Santa Clara 80
Beijing 50
Singapore 50
Ann Arbor 48
Woodbridge 48
Boardman 40
Princeton 38
Medford 35
Bremen 34
Caserta 34
San Mateo 30
Ashburn 25
Wilmington 24
Dearborn 21
Nanjing 20
New York 18
Istanbul 15
Munich 15
Kunming 14
Brussels 12
Auburn Hills 10
Jinan 10
Mugnano di Napoli 10
Roxbury 10
Düsseldorf 9
Hefei 9
Seoul 9
Cambridge 8
Des Moines 7
Los Angeles 7
Guangzhou 6
Napoli 6
Redwood City 6
Shanghai 6
Hebei 5
Houston 5
Nanchang 5
Hangzhou 4
Mountain View 4
Naples 4
Ningbo 4
Nocera Inferiore 4
Venice 4
Zhengzhou 4
Brno 3
Centrale 3
Falls Church 3
Ljubljana 3
San Sebastiano al Vesuvio 3
Shenyang 3
Amsterdam 2
Bologna 2
Brusciano 2
Changchun 2
Chongqing 2
Elice 2
Fairfield 2
Hampstead 2
Helsinki 2
Lanzhou 2
Lissone 2
London 2
Milan 2
Norwalk 2
Pistoia 2
Rome 2
Santiago 2
Voghera 2
Xian 2
Atlanta 1
Bloomington 1
Budenheim 1
Catanzaro 1
Changsha 1
Christchurch 1
Dallas 1
Elora 1
Fiano Romano 1
Florence 1
Fremont 1
Fuzhou 1
Groningen 1
Harbin 1
Huzhou 1
Jiaxing 1
Kansas City 1
Malden 1
Melrose 1
Merlo 1
Nanning 1
Nuremberg 1
Ottawa 1
Parma 1
Pomigliano d'Arco 1
Sacramento 1
Salerno 1
Sant'anastasia 1
Totale 1.680
Nome #
HNF-1β mutation affects PKD2 and SOCS3 expression causing renal cysts and diabetes in MODY5 kindred. 89
Endocannabinoid Research Group (ERG), Italy. The endovanilloid/endocannabinoid system: a new potential target for osteoporosis therapy. 89
Association Between a Polymorphism in Cannabinoid Receptor 2 and Severe Necroinflammation in Patients With Chronic Hepatitis C. 81
EP1 receptor within the ventrolateral periaqueductal grey controls thermonociception and rostral ventromedial medulla cell activity in healthy and neuropathic rat 80
Cannabinoid receptor type 2 functional variant influences liver damage in children with non-alcoholic fatty liver disease 79
Changes in cannabinoid receptor subtype 1 activity and interaction with metabotropic glutamate subtype 5 receptors in the periaqueductal gray-rostral ventromedial medulla pathway in a rodent neuropathic pain model. 77
The cannabinoid receptor type 2 as mediator of mesenchymal stromal cell immunosuppressive properties. 76
The blockade of the transient receptor potential vanilloid type 1 and fatty acid amide hydrolase decreases symptoms and central sequelae in the medial prefrontal cortex of neuropathic rats. 75
The 17-β-oestradiol inhibits osteoclast activity by increasing the cannabinoid CB2 receptor expression. 73
null 71
CNR2 functional variant (Q63R) influences childhood immune thrombocytopenic purpura. 71
The A1 adenosine receptor as a new player in microglia physiology 69
TNF-α effect on human delivery onset by CB1/TRPV1 crosstalk: new insights into endocannabinoid molecular signaling in preterm vs. term labor. Analysis of the EC/EV pathway and predictive biomarkers for early diagnosis of preterm delivery 69
The genetic ablation or pharmacological inhibition of TRPV1 signalling is beneficial for the restoration of quiescent osteoclast activity in ovariectomized mice. 68
The cannabinoid receptor type 2 Q63R variant increases the risk of celiac disease: implication for a novel molecular biomarker and future therapeutic intervention. 67
Effects of a metabotropic glutamate receptor subtype 7 negative allosteric modulator in the periaqueductal grey on pain responses and rostral ventromedial medulla cell activity in rat 65
Atypical gating of M-type potassium channels conferred by mutations in uncharged residues in the S4 region of KCNQ2 causing benign familial neonatal convulsions 65
The 17-estradiol inhibits osteoclast activity by increasing the cannabinoid CB2 receptor expression 65
A novel KCNQ2 K+ channel mutation in benign neonatal convulsions and centrotemporal spikes 64
Benign Familial Neonatal Seizures 64
A novel hyperekplexia-causing mutation in the pre-transmembrane segment 1 of the human glycine receptor alpha1 subunit reduces membrane expression and impairs gating by agonists 63
A mutation (V260M) in the middle of the M2 pore-lining domain of the glycine receptor causes hereditary hyperekplexia 63
Iron overload causes osteoporosis in Thalassemia Major patients through interaction with TRPV1 channels. 63
Palmitoylethanolamide reduces formalin-induced neuropathic-like behaviour through spinal glial/microglial phenotypical changes in mice 63
A novel mutation (R218Q) at the boundary between the N-terminal and the first transmembrane domain of the glycine receptor in a case of sporadic hyperekplexia 62
Cannabinoid Receptor 2 (CB2) Q63 variant in chronic hepatitis C: an association with a more severe hepatocellular necrosis. 62
Association of the cannabinoid receptor 2 (CB2) Gln63Arg polymorphism with indices of liver damage in obese children: An alternative way to highlight the CB2 hepatoprotective properties. 61
Decreased subunit stability as a novel mechanism for potassium current impairment by a KCNQ2 C terminus mutation causing benign familial neonatal convulsions 60
Cannabinoid receptor 2 (CB2) Q63 variant is associated with a severe histological activity index in patients with chronic hepatitis C 60
Mutational scanning of potassium, sodium and chloride ion channels in malignant migrating partial seizures in infancy 55
Hyperekplexia caused by dominant-negative suppression of glyra1 function 52
La presenza della variante Q63 del recettore dei cannabinoidi (CB2) si associa ad un più severa epatonecrosi nei pazienti con epatite cronica C. 52
Neutralization of a unique, negatively-charged residue in the voltage sensor of K V 7.2 subunits in a sporadic case of benign familial neonatal seizures 51
Benign Familial Neonatal Seizures . In: editors. Seattle (WA): Apr 27 46
Familial occurrence of early-onset childhood absence epilepsy 43
Benign familial neonatal convulsions (BFNC) resulting from mutation of the KCNQ2 voltage sensor 43
No evidence for association between dyslexia and DYX1C1 functional variants in a group of children and adolescents from Southern Italy. 40
The endovanilloid/endocannabinoid system in human osteoclasts: Possible involvement in bone formation and resorption 35
EXCLUSION DE LINKAGE A 8Q24 DANS UNE FAMILLE AVEC ABSENCE DE L'ENFANCE A DEBUT PRECOCE ET TOLERANCE REDUITE AU VPA 34
The CB2-63 RR variant is an independent predictor of severe liver necroinflammation in chronic hepatitis B 32
Cannabinoid receptor 2-63 QQ variant is associated with persistently normal aminotransferase serum levels in chronic hepatitis C 30
null 26
Totale 2.553
Categoria #
all - tutte 9.909
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.909


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020310 0 0 0 0 52 30 104 51 32 24 10 7
2020/2021341 37 0 50 14 58 5 45 34 2 51 30 15
2021/2022286 33 3 0 6 91 3 8 6 6 51 20 59
2022/2023768 47 31 15 100 93 70 0 46 331 9 9 17
2023/2024226 29 7 5 24 67 25 5 22 0 6 15 21
2024/2025173 4 19 13 32 105 0 0 0 0 0 0 0
Totale 2.553